Embed Multiple Sclerosis - New Drug - Infographic on your site
A newly-tested treatment for multiple sclerosis reduces relapse and deterioration in patients, without many of the negative side effects associated with other treatments, says a study.
A clinical study published Wednesday in the New England Journal of Medicine (NEJM) said that Cladribine was the first oral medication for patients suffering from MS, a complex neurological condition.
